Parkinsonism, levodopa, and anesthesia.
D000547:Amantadine / Q000627:therapeutic use; D000758:Anesthesia; D000818:Animals; D001058:Apomorphine / Q000627:therapeutic use; D001544:Benperidol / Q000009:adverse effects; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002395:Catecholamines / Q000096:biosynthesis; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D005283:Fentanyl / Q000009:adverse effects; D006801:Humans; D051379:Mice; D009069:Movement Disorders / Q000139:chemically induced; D009127:Muscle Rigidity / Q000209:etiology; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011654:Pulmonary Edema / Q000209:etiology; D051381:Rats
D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D001544:Benperidol; D000547:Amantadine; D001058:Apomorphine; D005283:Fentanyl; D004298:Dopamine